News

VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial service to pharma companies, was ...
Linda Nolan's stepson, who was suffering from metastatic throat cancer, has sadly died four months after the singer passed ...
A man struck by terminal cancer has urged the public to watch out for subtle changes after he was hit with deadly cancer that ...
Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...
A STUDENT from Jersey is carrying out a new project to better understand and find new ways to treat a chronic liver disease as part of her PhD studies. Former Hautlieu student Millie-Rose Doolan is ...
On a 5-point Likert scale, AI responses scored a 4.2 on both quality and empathy compared with scores of 3.0 on quality and 2 ...
Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...
SAN DIEGO -- A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) ...
Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...
Health officials in Los Angeles County have declared a community-wide outbreak of hepatitis A following a sharp rise in cases ...
Lacking awareness of metabolic dysfunction-associated steatohepatitis (MASH) constitutes a critical barrier for enhancing patient care, said Naim Alkhouri, MD. Awareness efforts can not only increase ...
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...